Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections
Year: 2024
Type: article
Abstract: This study evaluates the frequency of terminal disclaimers filed by drug patent holders to obviate obviousness-type double patenting rejections associated with drug patent thickets.
Source: JAMA
Authors: S. Sean Tu, Aaron S. Kesselheim, Bernard Chao
Language: English
Subfield: Management of Technology and Innovation
Domain: Social Sciences
Open Access status: green
OpenAlex ID: W4401511427
